Another tumor suppressor factor, Schlafen 11 (SLFN11), was also suggested to participate in drug resistance/sensitivity, and both ATM upregulation and SLFN11 downregulation can activate EMT to stimulate resistance of tumor cells to cisplatin-based chemotherapy [92,93]. This evidence concerns the gene SLFN11 and neoplasm.